Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2009

01-10-2009 | REVIEW

Inborn errors of metabolism and motor disturbances in children

Authors: A. García-Cazorla, N. I. Wolf, M. Serrano, B. Pérez-Dueñas, M. Pineda, J. Campistol, E. Fernández-Alvarez, J. Colomer, S. DiMauro, G. F. Hoffmann

Published in: Journal of Inherited Metabolic Disease | Issue 5/2009

Login to get access

Summary

Motor disturbances are very common in paediatric neurology. Often families can be reassured that these are just variants of normal development. However, abnormal movements can also be the hallmark of severe brain dysfunction of different and complex origins. This review concentrates on motor disturbances as frequent and important symptoms of inborn errors of metabolism. A structured diagnostic approach is developed taking into account age-dependent physiological developments and pathophysiological responses of gross and fine motor functions. A series of investigations are presented with the primary aim of early diagnosis of treatable conditions. The correct recognition and differentiation of movement disorders (ataxia, rigid akinetic syndrome (‘parkinsonism’), dystonia, athetosis, tremor, and others), spasticity, and neuromuscular disorders, requires profound neurological expertise. A high level of suspicion and close interaction between paediatric neurologists and specialists in inborn errors of metabolism are indispensable to effectively and timely identify patients in whom motor disturbances are the presenting and/or main symptom of an inborn error.
Literature
go back to reference Assmann B, Surtees R, Hoffmann GF (2003) Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 54(Suppl 6):S18–24CrossRefPubMed Assmann B, Surtees R, Hoffmann GF (2003) Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 54(Suppl 6):S18–24CrossRefPubMed
go back to reference Baumgartner MR, Verhoeven NM, Jakobs C et al (1998) Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig–Hoffmann disease. Neurology. 51:1427–1432CrossRefPubMed Baumgartner MR, Verhoeven NM, Jakobs C et al (1998) Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig–Hoffmann disease. Neurology. 51:1427–1432CrossRefPubMed
go back to reference Bouillot S, Martin-Négrier ML, Vital A et al (2002) Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature J Peripher Nerv Syst 7:213–220CrossRefPubMed Bouillot S, Martin-Négrier ML, Vital A et al (2002) Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature J Peripher Nerv Syst 7:213–220CrossRefPubMed
go back to reference Davidzon G, Greene P, Mancuso M et al (2006) Early-onset familial Parkinsonism due to POLG mutations. Ann Neurol 59:859–862CrossRefPubMed Davidzon G, Greene P, Mancuso M et al (2006) Early-onset familial Parkinsonism due to POLG mutations. Ann Neurol 59:859–862CrossRefPubMed
go back to reference Debray FG, Lambert M, Vanasse M et al (2006) Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 165:462–466CrossRefPubMed Debray FG, Lambert M, Vanasse M et al (2006) Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 165:462–466CrossRefPubMed
go back to reference Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112CrossRefPubMed Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112CrossRefPubMed
go back to reference Desnick RJ, Schindler D (2001) Alpha-N-acetylgalactosaminidase deficiency: Schindler disease. In: Scriver CR, Beaudet al Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3483–3505 Desnick RJ, Schindler D (2001) Alpha-N-acetylgalactosaminidase deficiency: Schindler disease. In: Scriver CR, Beaudet al Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3483–3505
go back to reference De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325(10):703–709CrossRefPubMed De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325(10):703–709CrossRefPubMed
go back to reference Espinós C, Pineda M, Martínez-Rubio D (2009) Mutations in the urocanase gene UROC1 are associated with urocanic aciduria. J Med Genet (in press) Espinós C, Pineda M, Martínez-Rubio D (2009) Mutations in the urocanase gene UROC1 are associated with urocanic aciduria. J Med Genet (in press)
go back to reference Fernández-Alvarez E, General concepts In: Fernández-Alvarez E, Aicardi J (eds) (2001) Movement disorders in children. MacKeith Press, London, pp 1–23 Fernández-Alvarez E, General concepts In: Fernández-Alvarez E, Aicardi J (eds) (2001) Movement disorders in children. MacKeith Press, London, pp 1–23
go back to reference Garcia-Cazorla A, Rabier D, Touati G et al (2006) Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 59:121–127CrossRefPubMed Garcia-Cazorla A, Rabier D, Touati G et al (2006) Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 59:121–127CrossRefPubMed
go back to reference Gouider-Khouja N, Ben Youssef-Turki I (2006) [Type I glutaric aciduria: an unrecognized cause of progressive dystonia] Rev Neurol (Paris) 162(8–9):858–861CrossRef Gouider-Khouja N, Ben Youssef-Turki I (2006) [Type I glutaric aciduria: an unrecognized cause of progressive dystonia] Rev Neurol (Paris) 162(8–9):858–861CrossRef
go back to reference Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17(23):3822–3835CrossRefPubMed Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17(23):3822–3835CrossRefPubMed
go back to reference Hoffmann GF, Surtees RA, Wevers RA (1998) Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 29:59–71CrossRefPubMed Hoffmann GF, Surtees RA, Wevers RA (1998) Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 29:59–71CrossRefPubMed
go back to reference Holmgren G, Brundin A, Gustavson KH, Sjögren S, Kleijer WJ, Niermeijer MF (1980) Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant. Neuropediatrics 11(4):377–383CrossRefPubMed Holmgren G, Brundin A, Gustavson KH, Sjögren S, Kleijer WJ, Niermeijer MF (1980) Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant. Neuropediatrics 11(4):377–383CrossRefPubMed
go back to reference Homer VM, George PM, Du Toit S, Davidson JS, Wilson CJ (2005) Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia. Ann Neurol 58:160–163CrossRefPubMed Homer VM, George PM, Du Toit S, Davidson JS, Wilson CJ (2005) Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia. Ann Neurol 58:160–163CrossRefPubMed
go back to reference Hyland K, Gibson KM, Sharma R, Van Hove JLK, Hoffmann GF (2009) Neurotransmitter disorders. In: Sarafoglu K, Hoffmann GF, Roth K (eds). Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 789–820 Hyland K, Gibson KM, Sharma R, Van Hove JLK, Hoffmann GF (2009) Neurotransmitter disorders. In: Sarafoglu K, Hoffmann GF, Roth K (eds). Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 789–820
go back to reference Kleta R, Romeo E, Ristic Z et al (2004) Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet 36(9):999–1002CrossRefPubMed Kleta R, Romeo E, Ristic Z et al (2004) Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet 36(9):999–1002CrossRefPubMed
go back to reference Kurian MA, Morgan NV, MacPherson L et al (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene. Neurology 70(18):1623–1629CrossRefPubMed Kurian MA, Morgan NV, MacPherson L et al (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene. Neurology 70(18):1623–1629CrossRefPubMed
go back to reference Kurian MA, Zhen J, Cheng SY et al (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest 119(6):1595–1603PubMedPubMedCentral Kurian MA, Zhen J, Cheng SY et al (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest 119(6):1595–1603PubMedPubMedCentral
go back to reference Lacomis D, Roeske-Anderson L, Mathie L (2005) Neuropathy and Fabry’s disease. Muscle Nerve 31:102–107CrossRefPubMed Lacomis D, Roeske-Anderson L, Mathie L (2005) Neuropathy and Fabry’s disease. Muscle Nerve 31:102–107CrossRefPubMed
go back to reference Lyon G, Fattal-Valevski A, Kolodny EH (2006) Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging. 17:219–242CrossRefPubMed Lyon G, Fattal-Valevski A, Kolodny EH (2006) Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging. 17:219–242CrossRefPubMed
go back to reference Mariotti C, Gellera C, Rimolid M et al (2004) Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci 25:130–137CrossRefPubMed Mariotti C, Gellera C, Rimolid M et al (2004) Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci 25:130–137CrossRefPubMed
go back to reference Marzouki N, Benomar A, Yahyaoui M et al (2005) Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet 48:21–28CrossRefPubMed Marzouki N, Benomar A, Yahyaoui M et al (2005) Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet 48:21–28CrossRefPubMed
go back to reference Mitchell G, Larochelle J, Lambert M et al (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322:432–437CrossRefPubMed Mitchell G, Larochelle J, Lambert M et al (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322:432–437CrossRefPubMed
go back to reference Morgan NV, Westaway SK, Morton JE et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38:752–754CrossRefPubMedPubMedCentral Morgan NV, Westaway SK, Morton JE et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38:752–754CrossRefPubMedPubMedCentral
go back to reference Moser H (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508CrossRefPubMed Moser H (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508CrossRefPubMed
go back to reference Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM (2007) Mitochondrial disease mimicking Charcot–Marie–Tooth disease. J Neurol Neurosurg Psychiatry 78:99–100CrossRefPubMedPubMedCentral Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM (2007) Mitochondrial disease mimicking Charcot–Marie–Tooth disease. J Neurol Neurosurg Psychiatry 78:99–100CrossRefPubMedPubMedCentral
go back to reference Oskoui M, Davidzon G, Pascual J et al (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122–1126CrossRefPubMed Oskoui M, Davidzon G, Pascual J et al (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122–1126CrossRefPubMed
go back to reference Overweg-Plandsoen WC, Groener JE et al (2003) GLUT-1 deficiency without epilepsy—an exceptional case. J Inherit Metab Dis 26:559–563CrossRefPubMed Overweg-Plandsoen WC, Groener JE et al (2003) GLUT-1 deficiency without epilepsy—an exceptional case. J Inherit Metab Dis 26:559–563CrossRefPubMed
go back to reference Pons R, Andreetta F, Wang CH et al (1996) Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 15:153–158CrossRefPubMed Pons R, Andreetta F, Wang CH et al (1996) Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 15:153–158CrossRefPubMed
go back to reference Poretti A, Wolf NI, Boltshauser E (2008) Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol 12(3):155–167CrossRefPubMed Poretti A, Wolf NI, Boltshauser E (2008) Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol 12(3):155–167CrossRefPubMed
go back to reference Ramaekers VT, Brab M, Rau G, Heimann G (1993) Recovery from neurological deficits following biotin treatment in a biotinidase K m variant. Neuropediatrics 24:98–102CrossRefPubMed Ramaekers VT, Brab M, Rau G, Heimann G (1993) Recovery from neurological deficits following biotin treatment in a biotinidase K m variant. Neuropediatrics 24:98–102CrossRefPubMed
go back to reference Ramaekers VT, Rothenberg SP, Sequeira JM et al (2005) Autoantibodies to folate receptor in the cerebral folate deficiency syndrome. N Engl J Med 352:1985–1991CrossRefPubMed Ramaekers VT, Rothenberg SP, Sequeira JM et al (2005) Autoantibodies to folate receptor in the cerebral folate deficiency syndrome. N Engl J Med 352:1985–1991CrossRefPubMed
go back to reference Robinson BH, MacKay N, Chun K, Ling M (1996) Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J Inherit Metab Dis 19(4):452–462CrossRefPubMed Robinson BH, MacKay N, Chun K, Ling M (1996) Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J Inherit Metab Dis 19(4):452–462CrossRefPubMed
go back to reference Salvi S, Santorelli FM, Bertini E et al (2001) Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Neurology 57(5):911–914CrossRefPubMed Salvi S, Santorelli FM, Bertini E et al (2001) Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Neurology 57(5):911–914CrossRefPubMed
go back to reference Saudubray JM, Martin D, de Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22(4):488–502CrossRefPubMed Saudubray JM, Martin D, de Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22(4):488–502CrossRefPubMed
go back to reference Scaglia F, Lee B (2006) Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 142:113–120CrossRef Scaglia F, Lee B (2006) Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 142:113–120CrossRef
go back to reference Sedel F, Barnerias C, Dubourg O, Desguerres I, Lyon-Caen O, Saudubray JM (2007) Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis 30:642–653CrossRefPubMed Sedel F, Barnerias C, Dubourg O, Desguerres I, Lyon-Caen O, Saudubray JM (2007) Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis 30:642–653CrossRefPubMed
go back to reference Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) Ann Neurol 54(Suppl 6):S32–45CrossRefPubMed Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) Ann Neurol 54(Suppl 6):S32–45CrossRefPubMed
go back to reference Siebner HR, Berndt S, Conrad B (1996) Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco–Sjoegren syndrome: a case report. J Neurol Neurosurg Psychiatry 60(5):582–585CrossRefPubMedPubMedCentral Siebner HR, Berndt S, Conrad B (1996) Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco–Sjoegren syndrome: a case report. J Neurol Neurosurg Psychiatry 60(5):582–585CrossRefPubMedPubMedCentral
go back to reference Spiekerkoetter U, Bennett MJ, Ben-Zeev B, Strauss AW, Tein I (2004) Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 29:66–72CrossRefPubMed Spiekerkoetter U, Bennett MJ, Ben-Zeev B, Strauss AW, Tein I (2004) Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 29:66–72CrossRefPubMed
go back to reference Strauss KA, Morton DH, Puffenberger EG et al (2007) Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 91(2):165–175CrossRefPubMed Strauss KA, Morton DH, Puffenberger EG et al (2007) Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 91(2):165–175CrossRefPubMed
go back to reference Suls A, Dedeken P, Goffin K et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131(Pt 7):1831–44CrossRefPubMedPubMedCentral Suls A, Dedeken P, Goffin K et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131(Pt 7):1831–44CrossRefPubMedPubMedCentral
go back to reference Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157:S118–S121CrossRefPubMed Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157:S118–S121CrossRefPubMed
go back to reference Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:8782–87831550–1554CrossRefPubMed Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:8782–87831550–1554CrossRefPubMed
go back to reference Tuschl K, Mills PB, Parsons H et al (2008) Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—a new metabolic disorder. J Inherit Metab Dis 31(2):151–163CrossRefPubMed Tuschl K, Mills PB, Parsons H et al (2008) Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—a new metabolic disorder. J Inherit Metab Dis 31(2):151–163CrossRefPubMed
go back to reference Verrips A, Hoefsloot LH, Steen Bergen GC et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123:908–919CrossRefPubMed Verrips A, Hoefsloot LH, Steen Bergen GC et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123:908–919CrossRefPubMed
go back to reference Wanders RJ (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83:16–27CrossRefPubMed Wanders RJ (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83:16–27CrossRefPubMed
go back to reference Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57(1):111–118CrossRefPubMed Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57(1):111–118CrossRefPubMed
Metadata
Title
Inborn errors of metabolism and motor disturbances in children
Authors
A. García-Cazorla
N. I. Wolf
M. Serrano
B. Pérez-Dueñas
M. Pineda
J. Campistol
E. Fernández-Alvarez
J. Colomer
S. DiMauro
G. F. Hoffmann
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1194-9

Other articles of this Issue 5/2009

Journal of Inherited Metabolic Disease 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.